𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I trial of the novel platinum analog ZD0473 in combination with gemcitabine in patients with advanced cancer

✍ Scribed by P. O'Dwyer; J. Stevenson; M. Redlinger; W. Sun; B. Giantonio; S. Hahn; K. Algazy; M. Burnite; M. Koehler


Book ID
117658114
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
182 KB
Volume
37
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase I clinical trial of bortezomib in
✍ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and dose‐limiting toxicities (DLTs) of bortezomib in combi